Sputnik V (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sputnik V" in Swedish language version.

refsWebsite

Global rank Swedish rank

13sputnikvaccine.com

low place

low place

5^th place

9^th place

low place

low place

2^nd place

14^th place

4^th place

17^th place

7^th place

26^th place

1indianexpress.com

60^th place

1,611^th place

49^th place

114^th place

2,393^rd place

1,895^th place

204^th place

506^th place

68^th place

52^nd place

220^th place

664^th place

cnbc.com

AstraZeneca to work on Covid vaccine combinations with Russia’s Sputnik V developers på CNBC den 11 december 2020

doi.org

dx.doi.org

Logunov, Denis Y; Dolzhikova, Inna V; Zubkova, Olga V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V; Dzharullaeva, Alina S (2020). ”Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia”. Lancet (London, England) 396 (10255): sid. 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. PMC: 7471804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/. Läst 31 december 2020.
Jones, Ian; Roy, Polly (2021-02-02). ”Sputnik V COVID-19 vaccine candidate appears safe and effective” (på english). The Lancet 0 (0). doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract. Läst 2 februari 2021.

dw.com

Welle (www.dw.com), Deutsche. ”Russia's Sputnik V COVID vaccine highly effective, new study shows | DW | 02.02.2021” (på brittisk engelska). DW.COM. https://www.dw.com/en/russias-sputnik-v-covid-vaccine-highly-effective-new-study-shows/a-56416767. Läst 3 februari 2021.

europa.eu

ema.europa.eu

”EMA starts rolling review of the Sputnik V Covid-19 vaccine”. Europeiska läkemedelsmyndigheten. 4 mars 2021. https://www.ema.europa.eu/en/news/ema-starts-rolling-review-sputnik-v-covid-19-vaccine. Läst 4 mars 2021.

gamaleya.org

”Vaccine against COVID-19” (på engelska). gamaleya.org. https://gamaleya.org/en/research/vaktsina-protiv-covid-19/. Läst 30 december 2020.
”Ebola”. gamaleya.org. https://gamaleya.org/en/research/ebola/. Läst 30 december 2020.

indianexpress.com

Covid-19 vaccine tracker, July 30: Russian vaccine to be ready by August 12 i Indian Express den 31 juli 2020

nih.gov

ncbi.nlm.nih.gov

Logunov, Denis Y; Dolzhikova, Inna V; Zubkova, Olga V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V; Dzharullaeva, Alina S (2020). ”Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia”. Lancet (London, England) 396 (10255): sid. 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. PMC: 7471804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/. Läst 31 december 2020.

nytimes.com

Corum, Jonathan; Zimmer, Carl. ”How Gamaleya’s Vaccine Works” (på amerikansk engelska). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2021/health/gamaleya-covid-19-vaccine.html. Läst 13 april 2021.

reuters.com

Ivanova, Polina (11 november 2020). ”Russia says its Sputnik V COVID-19 vaccine is 92% effective” (på engelska). Reuters. https://www.reuters.com/article/health-coronavirus-russia-vaccine-idUSKBN27R0ZA. Läst 30 december 2020.

sputnikvaccine.com

About Vaccine på sputnikvaccine.com läst den 30 december 2020
”Partnerships | Official website vaccine against COVID-19 Sputnik V.”. sputnikvaccine.com. https://sputnikvaccine.com/partnerships/. Läst 30 december 2020.
”The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials”. sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/the-sputnik-v-vaccine-s-efficacy-is-confirmed-at-91-4-based-on-data-analysis-of-the-final-control-po/. Läst 30 januari 2021.
”Sputnik V demonstrates 97.6% efficacy according to the analysis of data of 3.8 million vaccinated persons in Russia” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-demonstrates-97-6-efficacy-according-to-the-analysis-of-data-of-3-8-million-vaccinated-per/. Läst 19 april 2021.
”EMA starts rolling review of Sputnik V” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/ema-starts-rolling-review-of-sputnik-v/. Läst 4 mars 2021.
”RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-stelis-biopharma-partner-to-supply-200-million-doses-of-the-sputnik-v-vaccine/. Läst 19 mars 2021.
”RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-virchow-biotech-partner-for-production-of-sputnik-v-vaccine-in-india/. Läst 22 mars 2021.
”RDIF and Hetero agree to produce over 100 million doses of the Sputnik V vaccine in India” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-hetero-agree-to-produce-over-100-million-doses-of-the-sputnik-v-vaccine-in-india/. Läst 29 mars 2021.
”RDIF and Panacea Biotec agree to produce 100 million doses of Sputnik V vaccine in India per year” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-panacea-biotec-agree-to-produce-100-million-doses-of-sputnik-v-vaccine-in-india-per-year/. Läst 5 april 2021.
”RDIF and Shenzhen Yuanxing Gene-tech agree to produce over 60 million doses of the Sputnik V vaccine in China” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-shenzhen-yuanxing-gene-tech-agree-to-produce-over-60-million-doses-of-the-sputnik-v-vaccine/. Läst 29 mars 2021.
”RDIF and TopRidge Pharma agree to produce over 100 million doses of the Sputnik V vaccine in China” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-topridge-pharma-agree-to-produce-over-100-million-doses-of-the-sputnik-v-vaccine-in-china/. Läst 1 april 2021.
”RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China”. Sputnik vaccine. 19 april 2021. https://sputnikvaccine.com/newsroom/pressreleases/rdif-and-hualan-biological-bacterin-agree-to-produce-over-100-million-doses-of-the-sputnik-v-vaccine/. Läst 19 april 2021.
”RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt” (på engelska). sputnikvaccine.com. http://sputnikvaccine.com/newsroom/pressreleases/rdif-and-minapharm-agree-to-produce-over-40-million-doses-of-the-sputnik-v-vaccine-in-egypt/. Läst 22 april 2021.

thelancet.com

Jones, Ian; Roy, Polly (2021-02-02). ”Sputnik V COVID-19 vaccine candidate appears safe and effective” (på english). The Lancet 0 (0). doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract. Läst 2 februari 2021.

worldcat.org

Logunov, Denis Y; Dolzhikova, Inna V; Zubkova, Olga V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V; Dzharullaeva, Alina S (2020). ”Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia”. Lancet (London, England) 396 (10255): sid. 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. PMC: 7471804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/. Läst 31 december 2020.
Corum, Jonathan; Zimmer, Carl. ”How Gamaleya’s Vaccine Works” (på amerikansk engelska). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2021/health/gamaleya-covid-19-vaccine.html. Läst 13 april 2021.
Jones, Ian; Roy, Polly (2021-02-02). ”Sputnik V COVID-19 vaccine candidate appears safe and effective” (på english). The Lancet 0 (0). doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract. Läst 2 februari 2021.